RenovoRx Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -15.7% | +750.9% | -55.4% | -79.8% | +453.8% | -0.3% | |
| – | -15.7% | +752.4% | -55.4% | -79.8% | +434.0% | +0.8% | |
| – | -14.7% | +746.4% | -71.1% | -73.3% | +509.9% | -1.8% | |
| – | -14.7% | +746.4% | -57.6% | -81.8% | +509.9% | -1.8% | |
| – | – | – | – | – | – | +223.3% | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | +1,958.4% | -94.3% | +17.5% | +305.3% | -18.5% | -26.6% | |
| – | +408.8% | -77.1% | +17.5% | +6.6% | +62.5% | +2.8% | |
| – | – | – | – | – | – | +59.1% | |
| – | -69.9% | +224.1% | +1.7% | +5.1% | +4.5% | +36.3% | |
| – | – | – | – | – | – | – | |
| – | -1,100.4% | – | -59.8% | -148.7% | – | +21.1% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +3.1% | +1.3% | +13.7% | +14.7% | +49.7% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.